Calibration of qualitative HBsAg assay results for quantitative HBsAg monitoring

Journal of Clinical Virology

Volumn 61, Issue 2, 2014, Pages 305-308

  Gunning, Hans ^a   Adachi, Dena ^a   Tang, Julian W ^a,b  

^a PROVINCIAL LABORATORY FOR PUBLIC HEALTH   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

HBsAg; HBV; Hepatitis B; Qualitative; Quantitative; Surface antigen

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; ANTIVIRUS AGENT;

ASSAY; CALIBRATION; HEPATITIS B; HUMAN; LETTER; MONITORING; PRIORITY JOURNAL; BLOOD; DIAGNOSTIC PROCEDURE; DRUG MONITORING; HEPATITIS B, CHRONIC; IMMUNOASSAY; STANDARDS;

ANTIVIRAL AGENTS; CALIBRATION; CLINICAL LABORATORY TECHNIQUES; DRUG MONITORING; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; IMMUNOASSAY;

EID: 84924086895     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2014.07.017     Document Type: Letter

References (9)

1. Nguyen T., Thompson A.J.V., Bowden S., Croagh C., Bell S., Desmond P.V., et al. Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia. J Hepatol 2010, 52:508-513.
2. Jaroszewicz J., Serrano B.C., Wursthorn K., Deterding K., Schlue J., Raupach R., et al. Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective. J Hepatol 2010, 52:514-522.
3. Seto W.-K., Wong D.K.-H., Fung J., Hung I.F.-N., Fong D.Y.-T., Yuen J.C.-H., et al. A large case-control study on the predictability of hepatitis B surface antigen levels three years before hepatitis B surface antigen seroclearance. Hepatology 2012, 56:812-819.
4. Hadziyannis E. Quantification of HBsAg in serum: characteristics of the assays. OA Hepatology 2013, 1:1-6.
5. Zoutendijk R., Hansen B.E., van Vuuren A.J., Boucher C.A.B., Janssen H.L.A. Serum HBsAg decline during long-term potent nucleos(t)ide analogue therapy for chronic hepatitis B and prediction of HBsAg loss. J Infect Dis 2011, 204:415-418.
6. Martinot-Peignoux M., Lapalus M., Asselah T., Marcellin P. The role of HBsAg quantification for monitoring natural history and treatment outcome. Liver Int 2013, 33:125-132.
7. National Institute for Health and Care Excellence (UK). Hepatitis B (chronic): diagnosis and management of chronic hepatitis B in children, young people and adults. NICE clinical guideline 165: guidance.nice.org.uk/cg165. Issued: June 2013.
8. Tuaillon E., Mondain A.-M., Nagot N., Ottomani L., Kania D., Nogue E., et al. Comparison of serum HBsAg quantitation by four immunoassays, and relationships of HBsAg level with HBV replication and HBV genotypes. PLOS ONE 2012, 7:e32143.
9. Congly S.E., Wong P., Al-Busafi S.A., Doucette K., Fung S.K., Ghali P., et al. Characterization of hepatitis B virus genotypes and quantitative hepatitis B surface antigen titres in North America tertiary referral liver centres. Liver Int 2013, 33:1363-1369.